# Dimethyl Fumarate Neuraxpharm 240 mg · 240.0000 mg · Gastro-resistant capsule, hard · 56 (56 x 1)



## Belgium

- **FAMHP** — [be.dose-10060.org](https://be.dose-10060.org)

## Codes

- **be-cti-extended** — `600444-01`
- **be-cnk** — `4636296`
- **be-cnk** — `7736234`
- **be-authorisation** — `EU/1/22/1637/007`
- **eu-number** — `EU/1/22/1637/007`

## Status

- **amp_status** — REVOKED
- **ampp_status** — REVOKED
- **commercialised_now** — False
- **lifecycle** — history
- **period_from** — 2023-12-13
- **supply_problem_now** — False
- **read** — 2026-11-15T03:58:09Z

## Holder

- Neuraxpharm Pharmaceuticals

## Proof

Record be:presentation:cti:600444-01 version 1, signed ES256 under dosidal-record-1.9dbf5d53.

## Related records in other markets

- [Dimethyl fumarate Neuraxpharm](https://dosidal.ai/pack/eu/EU-1-22-1637-007) — EU — same product (EU central number)
- [Dimethyl fumarate Neuraxpharm](https://dosidal.ai/pack/pl/152315) — PL — same product (EU central number)

A link shows how two records are related. It does not say one product can be used in place of another.

## Contact

Contact: the form at the bottom of https://dosidal.ai/#contact

---
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
Artificial intelligence makes mistakes. Dosidal is an information source, not a recommendation. Read the regulator.
Dosidal is operated by Dosidal AI Corp. Office: 6687 Nelson Avenue, Suite 304, West Vancouver, BC V7W 2B2, Canada.
© 2027 Dosidal AI Corp.
Dosidal · dosidal.ai · Surface 1.0 (2026-11-16)
